Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Diaspect Medical AB
AB
In liquidation
Org 5566781927
Other research and experimental development on natural sciences and engineering
· NACE 7219
Est. 2005
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other research and experimental development on natural sciences and engineering
/
Diaspect Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (5)
JA
Jan Anders Fredrik Lovén
Liquidator
Liquidator
2024
AM
Anna Matilda Sjödin
External Signatory
External Signatory
2024
WL
Wendy Lissette Fahlgren
Liquidator
Liquidator
2024
ME
Mattias Eriksson
Audit
Audit
2024
AC
Ann Charlott Bouvin
Auditor Substitute
Auditor Substitute
2024
Former (2)
AE
Anna Elisabeth Elander
Authorized Recipient of Service
Authorized Recipient of Service
2022 – 2024
AH
Anna Hélène Maria Westberg
Chief Auditor
Chief Auditor
2022 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (8)
JT
Jan Totte Dahlin
Board of Directors
2024 – 2024
RA
Richard Anthony Evans
Board of Directors
2022 – 2022
GU
Gerd Ulla Marina Jonsson
Deputy Board Member
2024 – 2024
MP
Marc Peter Davies
Board of Directors
2022 – 2024
DM
David Michael Salter
Chairman
2022 – 2024
JH
Julian Huw Baines
Chairman
2022 – 2022
OS
Olga Suckau
Board of Directors
2022 – 2024
RG
Ralf Gütlein
Board of Directors
2022 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ekf Diagnostics Holding Plc.
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Diaspect Medical AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
